Cairo – Mubasher: Egypt-based business-to-business (B2B) healthtech 30Med has raised pre-Seed funding for unknown value, according to a press release.
Founded in 2023 by Ayman Ragab, 30Med seeks to bridge the gap between pharmaceutical companies and physicians by providing interactive videos and conference events that highlight new medicines and facilitate ongoing learning.
In line with its objectives, 30Med will use the new funding to provide the necessary resources to further enhance its platform and widen its reach within the medical community.
Ayman Ragab, CEO of 30Med, commented: "This milestone not only validates the importance of our mission but also enables us to accelerate our efforts in transforming medical education.”
The platform reinforces a substantial user base, including doctors who are eager to stay informed and engaged with the latest advancements in medicine and pharmaceuticals.
As 30Med continues to grow and evolve, with the aim of reshaping the landscape of medical education.
